Molecular Genetics - Chronic Obstructive Pulmonary Disease - page 414

38. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1 -
antitrypsin deficiency. Lancet 1985; 1:152-154.
39. O'Brien ML, Buist NR, Murphey WH. Neonatal screening for alpha 1 -
antitrypsin deficiency. J Pediatrics 1978; 92:1006-1010.
40. Seersholm N, Kok-Jensen A, Dirksen A. Survival of patients with severe
a 1 - antitrypsin deficiency with special reference to non-index cases. Thorax
1994; 49:695-698.
41. Piitulainen E, Eriksson S. Decline in FEV 1 related to smoking status in indi-
viduals with severe alpha 1 -antitrypsin deficiency (PiZZ). Eur Respir J 1999;
13:247-251.
42. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 -antitrypsin deficiency: the clinical
and physiological features of pulmonary emphysema in subjects homozygous
for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest
1983; 77:14-27.
43. Larsson C. Natural history and life expectancy in severe alpha 1 -antitrypsin
deficiency, Pi Z. Acta Med Scand 1978; 204:345-351.
44. Black LF, Kueppers F. alpha 1 -antitrypsin deficiency in nonsmokers. Am Rev
Respir Dis 1978; 117:421-428.
45. Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational expo-
sure to airway irritants on lung function in non-smoking individuals with
alpha 1 -antitrypsin deficiency (PiZZ). Thorax 1997; 52:244-248.
46. Piitulainen E, Tornling G, Eriksson S. Environmental correlates of impaired
lung function in non-smokers with severe alpha 1 -antitrypsin deficiency (PiZZ).
Thorax 1998; 53:939-943.
47. Mayer AS, Stoller JK, Bucher Bartelson B, James Ruttenber A, Sandhaus
RA, Newman LS. Occupational exposure risks in individuals with PI Z
alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med 2000; 162:
553-558.
48. Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ. Variability of
pulmonary function in alpha 1 -antitrypsin deficiency: clinical correlates. Ann
Intern Med 1989; 111:982-991.
49. Seersholm N, Dirksen A, Kok-Jensen A. Airways obstruction and two year
survival in patients with severe alpha 1 -antitrypsin deficiency. Eur Respir J
1994; 7:1985-1987.
50. Novoradovsky A, Brantly ML, Waclawiw MA, Chaudhary PP, Ihara H, Qi L,
Eissa NT, Barnes PM, Gabriele KM, Ehrmantraut ME, Rogliani P, Moss J.
Endothelial nitric oxide synthase as a potential susceptibility gene in the
pathogenesis of emphysema in alpha 1 -antitrypsin deficiency. Am J Respir Cell
Mol Biol 1999; 20:441-447.
51. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG,
Eden E, Schluchter MD, Stoller JK. Clinical features of individuals with
PI SZ phenotype of a 1 -antitrypsin deficiency. a 1 -Antitrypsin Deficiency
Registry Study Group. Am J Respir Crit Care Med 1996; 154:1718-1725.
52. Alvarez-Granda L, Cabero-Perez MJ, Bustamante-Ruiz A, Gonzalez-
Lamuno D, Delgado-Rodriguez M, Garcia-Fuentes M. PI SZ phenotype in
chronic obstructive pulmonary disease. Thorax 1997; 52:659-661.